The Effect of Delayed Systemically Administered n-Acetylcysteine on the Cochlear Oxidative State and on Cisplatin Induced Ototoxicity In Vivo in Guinea Pigs

dc.contributor.authorSeaman, Michael
dc.date.accessioned2018-07-13T18:58:13Z
dc.date.available2018-07-13T18:58:13Z
dc.date.issued2015-08-07
dc.date.submitted2018-07-13T18:58:13Zen
dc.description.abstractCisplatin is an effective antineoplastic drug which is often limited in it‘s use by an ototoxic side effect. After cisplatin enters the cochlea, a large amount reactive oxygen species (ROS) is generated. This large production of ROS appears to overwhelm the cells’ mechanisms of ROS regulation and is thought to mediate damage to cells within the cochlea. Past studies have shown that the ototoxicity of cisplatin can be diminished when it is administered concurrently with an antioxidant such as n-acetylcysteine (NAC). It is thought that the mechanism of NAC’s action is through it’s ability to counteract the overwhelming ROS production. Unfortunately, a concern exists that the efficacy of cisplatin is reduced by the NAC when the two agents are administered concurrently. Our study was designed to circumvent this concern by administering NAC long after the cisplatin treatments have ended. Thus we could determine if the delayed administration of NAC could reverse the ototoxic effect of cisplatin, possibly without affecting the efficacy of cisplatin. In our study, guinea pigs were administered a course of cisplatin treatments. NAC was then administered 30 days after the completion of the cisplatin treatments. Auditory brainstem responses were used to determine hearing loss. A redox probe was used to measure the intracochlear oxidative states in vivo. NAC did not reverse the ototoxicity of cisplatin and was found to not change the intracochlear oxidative state. The results of this study suggest the possibility of a tolerance to the effect of systemically administered antioxidants.en_US
dc.description.sponsorshipH.T. Thorlakson Foundation Dean, Faculty of Medicine Manitoba Health Research Council Manitoba Institute of Child Health Kidney Foundation of Manitoba Leukemia and Lymphoma Society of Canada CancerCare Manitoba Manitoba Medical Service Foundation Associate Dean (Research), Faculty of Medicine Heart and Stroke Foundation Health Sciences Centre Research Foundationen_US
dc.identifier.urihttp://hdl.handle.net/1993/33173
dc.rightsopen accessen_US
dc.subjectn-acetylcysteine (NAC)en_US
dc.subjectCisplatinen_US
dc.subjectototoxicityen_US
dc.titleThe Effect of Delayed Systemically Administered n-Acetylcysteine on the Cochlear Oxidative State and on Cisplatin Induced Ototoxicity In Vivo in Guinea Pigsen_US
dc.typebachelor thesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Seaman, Michael.pdf
Size:
1.22 MB
Format:
Adobe Portable Document Format
Description:
BSc(Med) Final Research Report
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: